Depression and Diabetes in Older Adults

Diabetes in Old Age: Third Edition

Volumn , Issue , 2009, Pages 385-401

  Nouwen, Arie ^a   Oyebode, Jan R ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Assessment of depression in older adults with diabetes; Defining depression; Depression and diabetes in older adults; Depression in diabetes associated problems; Depression in older people; Epidemiology of depression in diabetes; Possible mechanisms for aetiology of depression

Indexed keywords

EID: 84886146691     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470744093.ch28     Document Type: Chapter

References (130)

1. World Health Organisation. ICD-10 Classification of Mental and Behavioural Disorders. World Health Organisation, Geneva; 1992.
2. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association; 1994.
3. Alexopoulos GS, Meyers BS, Young RC, Campbell S, Silbersweig D, Charlson M. 'Vascular depression' hypothesis. Arch Gen Psychiatry 1997; 54 (10): 915-22.
4. Bruce DG, Casey G, Davis WA, Starkstein SE, Clarnette RC, Foster JK, et al. Vascular depression in older people with diabetes. Diabetologia 2006; 49 (12): 2828-36.
5. Krishnan KR, Hays JC, Blazer DG. MRI-defined vascular depression. Am J Psychiatry 1997; 154 (4): 497-501.
6. Robinson RG. Poststroke depression: prevalence, diagnosis, treatment, and disease progression. Biol Psychiatry 2003; 54 (3): 376-87.
7. Lewinsohn PM, Rohde P, Seeley JR, Fischer SA. Age and depression: unique and shared effects. Psychol Aging 1991; 6(2): 247-60.
8. Roberts RE, Kaplan GA, Shema SJ, Strawbridge WJ. Does growing old increase the risk for depression? Am J Psychiatry 1997; 154 (10): 1384-90.
9. Chapman DP, Perry GS. Depression as a major component of public health for older adults. Prev Chronic Dis. 2008; 5(1): http://www.cdc.gov/pcd/issues/2008/jan/O7_Ol5O.htm (accessed December 2007).
10. Blazer D. The epidemiology of depression in late life. J Geriatr Psychiatry 1989; 22: 35-52.
11. Weissman MM, Leaf PJ, Tischler GL, Blazer DG, Karno M, Bruce ML, et al. Affective disorders in five United States communities. Psychol Med. 1988; 18 (1): 141-53.
12. Ames D. Epidemiological studies of depression among the elderly in residential and nursing homes. Int J Geriatr Psychiatry 1991; 6, 347-54.
13. Parmalee P, Katz I, Lawton M. The design of special environments for the aged. In: J. Birren and K. Schaie (eds), Handbook of the Psychology of Aging, 3rd edition. Academic Press, San Diego; 1992, pp. 464-88.
14. Van Ojen R, Hooijer C, Jonker C, Lindeboom J, van Tilburg W. Late-life depressive disorder in the community, early onset and the decrease of vulnerability with increasing age. J Affect Disord. 1995; 33 (3), 159-66.
15. Cole MG, Dendukuri N. Risk factors for depression among elderly community subjects: a systematic review and meta-analysis. Am J Psychiatry 2003; 160: 1147-56.
16. Zarit S, Zarit J. Mental Disorders in Older Adults: Fundamental of Assessment and Treatment. Guilford, New York; 1998.
17. Sharpe M, Hawton K, Seagroatt V, Bamford J, House A, Molyneux A, et al. Depressive disorders in long term survivors of stroke: associations with demographic and social factors, functional status and brain lesion volume. Br J Psychiatry 1994; 164 (3), 380-6.
18. National Institute of Health Consensus Development conference. Diagnosis and treatment of depression in late life. JAMA 1992; 268 (8): 1018-24.
19. Livingstone G, Hawkins A, Blizard B, Mann A. The Gospel Oak study: prevalence rates of dementia, depression and activity limitation among elderly residents in inner London. Psychol Med. 1990; 20 (1): 137-46.
20. Blazer D, Hughes D, George L. The epidemiology of depression in an elderly community population. Gerontologist 1987; 27: 281-7.
21. Anderson RJ, Freedland KE, Clouse RE, Lustman PJ. The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care 2001; 24 (6), 1069-78.
22. Ali S, Stone MA, Peters JL, Davies MJ, Kunti K. The prevalence of co-morbid depression in adults with type 2 diabetes: a systematic review and meta-analysis. Diabet Med. 2006; 23 (11): 1165-73.
23. Zahid N, Asghar S, Claussen B, Hussain A. Depression and diabetes in a rural community in Pakistan. Diabet Res Clin Prac. 2008; 79 (1): 124-7.
24. Khamseh ME, Baradaran HR, Rajabali H. Depression and diabetes in Iranian patients: a comparative study. Int J Psychiatry Med. 2007; 37 (1): 81-6.
25. Chou KL, Chi I. Functional disability related to diabetes mellitus in older Hong Kong Chinese adults. Gerontologist 2005; 51: 334-9.
26. Egede LE. Major depression in individuals with chronic medical disorders: prevalence, correlates and association with health resource utilization, lost productivity and functional disability. Gen Hosp Psychiatry 2007; 29 (5): 409-16.
27. Patten SB, Beck CA, Kassam A, Williams JV, Barbui C, Metz LM. Long-term medical conditions and major depression: strength of association for specific conditions in the general population. Can J Psychiatry 2005; 50 (4): 195-202.
28. Peyrot M, Rubin RR. Persistence of depressive symptoms in diabetic adults. Diabetes Care 1999; 22 (3): 448-52.
29. Lustman PJ, Griffith LS, Clouse RE. Depression in adults with diabetes. Results of 5-yr follow-up study. Diabetes Care 1988; 11 (8): 605-12.
30. Pouwer F, Beekman AT, Nijpels G, Dekker JM, Snoek FJ, Kostense PJ, et al. Rates and risks for co-morbid depression in patients with Type 2 diabetes mellitus: results from a community-based study. Diabetologia 2003; 46 (7): 892-8.
31. Maraldi C, Volpato S, Penninx BW, Yaffe K, Simonsick EM, Strotmeyer ES, et al. Diabetes mellitus, glycemic control, and incident depressive symptoms among 70-to 79-year-old persons: the health, aging, and body composition study. Arch Intern Med. 2007; 167 (11): 1137-44.
32. De Jonghe P, Roy J, Saz P, Marcos G, Lobo A, ZARADEMP investigators. Prevalent and incident depression in community dwelling elderly persons with diabetes mellitus: results from the ZARADEMP project. Diabetologia 2006; 49 (11): 2627-33.
33. Bisschop MI, Kriegsman DM, Deeg DJ, Beekman AT, van Tilburg W. The longitudinal relation between chronic diseases and depression in older persons in the community: the Longitudinal Aging Study Amsterdam. J Clin Epidemiol. 2004; 57: 187-94.
34. Palinkas LA, Lee PP, Barrett-Connor E. A prospective study of Type 2 diabetes and depressive symptoms in the elderly: the Rancho Bernardo Study. Diabet Med. 2004; 21 (11): 1185-91.
35. Janssen J, Beekman AT, Comijs HC, Deeg DJ, Heeren TJ. Late-life depression: the differences between early-and late-onset illness in a community-based sample. Int J Geriatr Psychiatry 2006; 21 (1): 86-93.
36. Simpson S, Baldwin R, Jackson A, Burns A, Thomas P. Is the clinical expression of late-life depression influenced by brain changes? MRI subcortical neu-roanatomical correlates of depressive symptoms. Int Psychogeriatr. 2000; 12 (4): 425-34.
37. Kessing LV. Differences in diagnostic subtypes among patients with late and early onset of a single depressive episode. Int J Geriatr Psychiatry. 2006; 21 (12): 1127-31.
38. Mendlewicz J. The age factor in depressive illness: some genetic considerations. J Gerontol. 1976; 31 (3): 300-3.
39. Kalsekar ID, Madhaven SS, Amonkar MM, Makela EH, Scott VG, Douglas SM, et al. Depression in patients with type 2 diabetes: impact on adherence to oral hypoglycemic agents. Ann Pharmacother. 2006; 40 (4): 605-11.
40. Ciechanowski PS, Katon WJ, Russo JE. Impact of depressive symptoms on adherence, function, and costs. Arch Intern Med. 2000; 160: 3278-85.
41. Kilbourne AM, Reynolds CF, Good CB, Sereika SM, Justice AC, Fine MJ. How does depression influence diabetes medication adherence in older patients? Am J Geriatr Psychiatry. 2005; 13 (3): 202-10.
42. Gonzalez J, Safren S, Cagliero E, Wexler D, Delahanty L, Wittenberg E, et al. Depression, self-care, and medication adherence in type 2 diabetes: relationships across the full range of symptom severity. Diabetes Care 2007; 30 (9): 2222-7.
43. Park H, Hong Y, Lee H, Ha E, Sung Y. Individuals with type 2 diabetes and depressive symptoms exhibited lower adherence with self-care. J Clin Epidemiol. 2004; 57 (9): 978-84.
44. Ciechanowski PS, Katon WJ, Russo JE, Hirsch IB. The relationship of depressive symptoms to symptom reporting, self-care and glucose control in diabetes. Gen Hosp Psychiatry 2003; 25: 246-52.
45. Lustman PJ, Anderson RJ, Freedland KE, de Groot M, Carney RM, Clouse RE. Depression and poor glycemic control: a meta-analytic review of the literature. Diabetes Care 2000; 23 (7): 934-42.
46. Carney R, Freedland K, Lustman P, Griffith L. Depression and coronary disease in diabetic patients: a 10-year follow-up (Abstract). Psychosom Med. 1994; 56: 149.
47. Lloyd CE, Kuller LH, Ellis D, Becker DJ, Wing RR, Orchard TJ. Coronary artery disease in IDDM. Gender differences in risk factors but not risk. Arterioscler, Thromb Vasc Biol. 1996; 16 (6): 720-6.
48. de Groot M, Anderson R, Freedland KE, Clouse RE, Lustman PJ. Association of depression and diabetes complications: a meta-analysis. Psychosom Med. 2001; 63 (4): 619-30.
49. Egede LE, Zheng D, Simpson K. 2002 Comorbid depression is associated with increased health care use and expenditures in individuals with diabetes. Diabetes Care 2002; 25 (3): 464-70.
50. Zhang X, Norris SL, Gregg EW, Cheng YJ, Beckles G, Kahn HS. Depressive symptoms and mortality among persons with and without diabetes. Am J Epidemiol. 2005; 161 (7): 652-60.
51. Egede LE, Nietert PJ, Zheng D. Depression and all-cause and coronary heart disease mortality among adults with and without diabetes. Diabetes Care 2005; 28 (6): 1339-45.
52. Black SA, Markides KS, Ray LA. Depression predicts increased incidence of adverse health outcomes in older Mexican Americans with type 2 diabetes. Diabetes Care 2003; 26: 2822-8.
53. Gallo JJ, Bogner HR, Morales KH, Post EP, Ten Have T, Bruce ML. Depression, cardiovascular disease, diabetes, and two-year mortality among older, primary-care patients. Am J Geriatr Psychiatry. 2005; 13 (9): 748-55.
54. Bogner HR, Morales KH, Post EP, Bruce ML. Diabetes, depression, and death: a randomized controlled trial of a depression treatment program for older adults based in primary care (PROSPECT). Diabetes Care 2007; 30: 3005-10.
55. Katon WJ, Rutter C, Simon G, Lin EH, Ludman E, Ciechanowski P, Kinder L, et al. The association of comorbid depression with mortality in patients with type 2 diabetes. Diabetes Care 2005; 28 (11), 2668-72.
56. Southwick SM, Vythilingam M, Charney DS. The psychobiology of depression and resilience to stress: implications for prevention and treatment. Annu Rev Clin Psychol. 2005; 1: 255-91.
57. Talbot F, Nouwen A. A review of the relationship between depression and diabetes in adults: is there a link? Diabetes Care 2000; 23 (10): 1556-62.
58. Lustman PJ, Griffith LS, Freedland KE, Clouse RE. The course of major depression in diabetes. Gen Hosp Psychiatry 1997; 19 (2): 138-43.
59. Palinkas LA, Barrett-Connor E, Wingard DL. Type 2 diabetes and depressive symptoms in older adults: a population-based study. Diabet Med. 1991; 8 (6): 532-9.
60. Knol MJ, Heerdink ER, Egberts AC, Geerlings MI, Gorter KJ, Numans ME, et al. Depressive symptoms in subjects with diagnosed and undiagnosed type 2 diabetes. Psychosom Med. 2007; 69 (4): 300-5.
61. Banks SM, Kerns RD. Explaining high rates of depression in chronic pain: A Diathesis-stress framework. Psychological Bulletin 1996; 119, 95-110.
62. Murphy E. Social origins of depression in old age. Br J Psychiatry 1982; 141, 135-42.
63. Kessler RC. The effects of stressful life events on depression. Annu Rev Psychol. 1997; 48: 191-214.
64. Wikblad KF, Wibell LB, Montin KR. Health and unhealth in chronic disease. Scand J Caring Sci. 1991; 5 (2): 71-7.
65. National Institute of Clinical Excellence. Depression. Management of depression in Primary and Secondary Care. Clinical Guideline 23. NICE, London, 2004.
66. American Diabetes Association. Standards of Medical Care in Diabetes. Diabetes Care 2005; 28 (Suppl. 1): S4-36.
67. International Diabetes Federation. Global Guideline for type 2 diabetes. International Diabetes Federation, Brussels, Belgium; 2005, pp. 19-21.
68. Iliffe S, Haines A, Gallivan S, Booroff A, Goldenberg E, Morgan P. Assessment of elderly people in general practice. 1. Social circumstances and mental state. Br J Gen Pract. 1991; 41 (342), 9-12.
69. Henkel V, Mergl R, Kohnen R, Maier W, Moller HJ, Hegerl U. Identifying depression in primary care: a comparison of different methods in a prospective cohort study. Br Med J. 2003; 326 (7382): 200-1.
70. Brink T, Yesavage J, Lum O, Heersuma P, Adey M, Rose T. Screening tests for geriatric depression. Clinical Gerontologist 1982; 1: 37-43.
71. Yesavage J, Brink T, Rose T, Lum O, Huang V, Adey M, et al. Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatric Res. 1983; 17 (1): 37-49.
72. Shah A, Herbert R, Lewis S, Mehendran R, Platt J, Bhattacharyya B. Screening for depression among acutely ill geriatric inpatients with a short Geriatric Depression Scale. Age Ageing 1997; 26 (3): 217-21.
73. D'Ath P, Katona P, Mullan E, Evans S, Katona C. Screening, detection and management of depression in elderly primary care attenders. I: The acceptability and performance of the 15 item Geriatric Depression Scale (GDS15) and the development of short versions. Fam Pract. 1994; 11 (3): 260-6.
74. van Marwijk H, Wallace P, de Bock G, Hermans J, Kaptein A, Mulder JD. Evaluation of the feasibility, reliability and diagnostic value of shortened versions of the geriatric depression scale. Br J Gen Pract. 1995; 45 (393): 195-9.
75. Juurlink D, Herrmann N, Szalai J, Kopp A, Redelmeier D. Medical illness and the risk of suicide in the elderly. Arch Intern Med. 2004; 164 (11), 1179-84.
76. Sheikh J, Yesavage J. Geriatric Depression Scale: recent findings and development of a short version. In: T. Brink (ed.). Clinical Gerontology: A guide to assessment and intervention. Howarth Press, New York; 1986, pp. 165-73.
77. Yesavage J. Geriatric Depression Scale. Psychophar-macol Bull. 1988; 24 (4): 709-10.
78. Wall J, Lichtenberg P, MacNeill S, Deshpande S, Walsh P. Depression detection in geriatric rehabilitation: Geriatric Depression Scale Short Form vs. Long Form. Clin Gerontol. 1999; 20 (1): 13-21.
79. Stiles P, McGarrahan J. The Geriatric Depression Scale: a comprehensive review. J Clin Geropsychol. 1998; 4 (1), 89.
80. Watson L, Pignone M. Screening accuracy for late-life depression in primary care: A systematic review. J Fam Pract 2003; 52 (12), 956-64.
81. Abas M, Phillip C, Carter J, Walter S, Banerjee S, Levy R. Culturally sensitive validation of screening questionnaires for depression in older African-Caribbean people living in South London. Br J Psychiatry. 1998; 173; 249-54.
82. Rait G, Burns A, Baldwin R, Morley M, Chew-Graham C, St Leger AS, et al. Screening for depression in African Caribbean elders. Fam Pract. 1999; 16 (6): 591-5.
83. Alexopoulos G, Abrams R, Young R, Shamoian C. Cornell Scale for depression in dementia. Biol Psychiatry. 1988; 23 (3): 271-84.
84. Kørner A, Lauritzen L, Abelskov K, Gulmann N, Brodersen AM, Wedervang-Jensen T, et al. The Geriatric Depression Scale and the Cornell Scale for Depression in Dementia. A validity study. Nord J Psychiatry 2006; 60 (5): 360-4.
85. Kurlowicz L, Evans L, Strumpf N, Maislin G. A Psychometric Evaluation of the Cornell Scale for Depression in dementia in a frail, nursing home population. Am J Geriatr Psychiatry 2002; 10 (5): 600-8.
86. Radloff LS. The CES-D scale: A self-report depression scale for research in the general population. Appl Psychol Measurement. 1977; 1: 385-401.
87. Beck AT, Ward, CH, Mendelsohn M, Mock J, Erbaugh J. An inventory for measuring depression, Arch Gen Psychiatry 1961; 4: 561-71.
88. Lustman PJ, Clouse RE, Griffith LS, Carney RM and Freedland KE. Screening for depression in diabetes using the Beck Depression Inventory. Psychosom Med. 1997; 59 (1), 24-31.
89. Lustman PJ, Clouse RE, Griffith LS, Carney RM, Freedland KE. Screening for depression in diabetes using the Beck Depression Inventory. Psychosom Med. 1997; 59 (1): 24-31.
90. Hermanns N, Kulzer B, Krichbaum M, Kubiak T, Haak T. How to screen for depression and emotional problems in patients with diabetes: comparison of screening characteristics of depression questionnaires, measurement of diabetes-specific emotional problems and standard clinical assessment. Diabetologia 2006; 49 (3): 469-77.
91. de Rekeneire N, Rooks RN, Simonsick EM, Shorr RI, Kuller LH, Schwartz AV, et al. Health, Aging and Body Composition Study. Diabetes is associated with subclinical functional limitation in nondisabled older individuals: the Health, Aging, and Body Composition study. Diabetes Care 2003; 26 (7): 3257-63.
92. Wu JH, Haan MN, Liang J, Ghosh G, Gonzalez HM, Herman WH. Diabetes as a predictor of change in functional status among older Mexican Americans: A population-based cohort study. Diabetes Care 2003; 26 (2): 314-19.
93. Black SA, Goodwin JS, Markides KS. The association between chronic diseases and depressive symptomatology in older Mexican Americans. J Gerontol. 1998; 53A: M188-94.
94. Papassotiropoulos A, Heun R, Maier W. The impact of dementia on the detection of depression in elderly subjects from the general population. Psychol Med. 1999; 29 (1), 113-20.
95. UK National Institute for Health and Clinical Excellence (NICE) Depression. Management of depression in Primary and Secondary Care. Clinical Guideline 23 (amended). NICE, London; 2007.
96. Jacobson AM, Weinger K. Treating depression in diabetic patients: is there an alternative to medications? Ann Intern Med. 1998; 129 (8): 656-7.
97. Alexopoulos G, Katz I, Reynolds C, Carpenter D, Docherty JP. Expert consensus panel for pharmacotherapy of depressive disorders in older patients. The expert consensus guideline series. Pharmacotherapy of depressive disorders in older patients. Postgrad Med. 2001; Special No. Pharmacotherapy: 1-86.
98. Wilson K, Mottram P, Sivanranthan A, Nightingale A. Antidepressant versus placebo for depressed elderly. Cochrane Database of Systematic Reviews 2001; (2): CD000561.
99. Mottram P, Wilson K, Strobl J. Antidepressants for depressed elderly. Cochrane Database of Systematic Reviews 2006; (1): CD003491.
100. Gill D, Hatcher S. Antidepressants for depression in medical illness. Cochrane Database of Systematic Reviews 2000; (4): CD001312.
101. Gill, D. Hatcher, S. Antidepressants for depression in medical illness: Update. Cochrane Database of Systematic Reviews 2007; (4): CD001312.
102. Lustman PJ, Griffith LS, Clouse RE, Freedland KA, Eisen SA, Rubin EH, et al. Effects of nortriptyline on depression and glycemic control in diabetes: results of a double-blind, placebo controlled trial. Psychosom Med. 1997; 59 (3): 241-50.
103. McIntyre R, Soczynska J, Konarski J, Kennedy S. The effect of antidepressants on glucose homeostasis and insulin sensitivity: synthesis and mechanisms. Expert Opin Drug Saf. 2006; 5 (4): 157-68.
104. Taylor D, Paton C, Kerwin R. The South London and Maudsley & Oxleas Foundation Trust Prescribing Guidelines, 9th edition. Informa Healthcare, London; 2007.
105. Bazire S. Psychotropic Drug Directory. Fivepin Publishing, Wiltshire; 2003.
106. Lustman PJ, Freedland KE, Griffith LS, Clouse RE. Fluoxetine for depression in diabetes: a randomized double-blind placebo-controlled trial. Diabetes Care 2000; 23 (5): 618-23.
107. Gulseren L, Gülseren S, Hekimsoy Z, Mete L. Comparison of fluoxetine and paroxetine in type II diabetes mellitus patients. Arch Med Res. 2005; 36 (2): 159-65.
108. Goodnick P. Use of antidepressants in treatment of comorbid diabetes mellitus and depression as well as in diabetic neuropathy. Ann Clin Psychiatry 2001; 13 (1): 31-41.
109. Lustman PJ, Clouse RE, Nix BD, Freedland KE, Rubin EH, McGill JB, et al. Sertraline for prevention of depression recurrence in diabetes mellitus: a randomized, double-blind, placebo-controlled trial. Arch Gen Psychiatry 2006; 63 (5): 521-9.
110. Gray D, Fujioka K, Devine W, Bray G. A randomized double-blind clinical trial of fluoxetine in obese diabetics. Int J Obes Relat Metab Dis. 1992; 16 (Suppl. 4): S67-72.
111. Maheux P, Ducros F, Bourque J, Garon J, Chiasson J-L. Fluoxetine improves insulin sensitivity in obese patients with non-insulin-dependent diabetes mellitus independently of weight loss. Int J Obes Relat Metab Disord. 1997; 21 (2): 97-102.
112. Andrew, J.E., Prescott, P., Smith, T.M.F., Inman, W.H.W. and Kubota, K. Fluoxetine: another new antidepressive. Drug and Therapeutics Bulletin 1990; 28, 33.
113. Bazire S. Psychotropic Drug Directory. 7th edition. Fivepin Publishing, Wiltshire; 2007.
114. Raskin J, Smith T, Wong K, Pritchett Y, D'Souza D, Iyengar S, et al. Duloxetine versus routine care in the long-term management of diabetic peripheral neuropathic pain. J Palliat Med. 2006; 9 (1): 29-40.
115. McIntyre R, Mancini D, Pearce M, Silverstone P, Chue P, Misener VL et al. Mood and psychotic disorders and Type 2 diabetes: a metabolic triad. Can J Diabet. 2005; 29, 122-32.
116. Himmerich H, Fulda S, Schaaf L, Beitinger P, Schuld A, Pollmächer T. Changes in weight and glucose tolerance during treatment with mirtazapine. Diabetes Care 2006; 29 (1): 170.
117. Musselman D, Betan E, Larsen H, Phillips L. Relationship of depression to diabetes types 1 and 2: epidemiology, biology, and treatment. Biol Psychiatry 2003; 54 (3): 317-29.
118. UK National Institute for Health and Clinical Excellence (NICE) Depression. Management of depression in Primary and Secondary Care. Clinical Guideline 23 (amended). NICE, London; 2007.
119. Williams MM, Clouse RE, Nix BD, Rubin EH, Sayuk GS, McGill JB, et al. Efficacy of sertraline in prevention of depression recurrence in older versus younger adults with diabetes. Diabetes Care 2007; 30 (4): 801-6.
120. Valenstein M, Vijan S, Zeber JE, Boehm K, Buttar A. The cost-utility of screening for depression in primary care. Ann Intern Med. 2001; 134 (5): 345-60.
121. Lustman PJ, Griffith LS, Freedland KE, Kissel SS, Clouse RE. Cognitive behavior therapy for depression in type 2 diabetes. A randomized controlled trial. Ann Intern Med. 1998; 129 (8): 613-21.
122. Lustman PJ, Clouse RE, Freedland KE. Management of major depression in adults with diabetes: implications of recent clinical trials. Sem Clin Neuropsychiatry 1998; 3 (2): 102-14.
123. UK National Institute for Health and Clinical Excellence (NICE) Depression. Management of depression in Primary and Secondary Care. Clinical Guideline 23 (amended). NICE, London; 2007.
124. Williams JW Jr, Katon W, Lin EH, Noel PH, Worchel J, Cornell J, et al. The effectiveness of depression care management on diabetes-related outcomes in older patients. Ann Intern Med. 2004; 140 (12): 1015-24.
125. Katon W, Von Korff M, Lin E, Simon G, Ludman E, Russo J, et al. The Pathways Study: a randomized trial of collaborative care in patients with diabetes and depression. Arch Gen Psychiatry 2004; 61 (10): 1042-9.
126. Huang X, Song L, Li T. The effect of social support on type II diabetes with depression. Chin J Clin Psychol. 2001; 9, 187-9.
127. Ismail K, Winkley S, Rabe-Hesketh. Systematic review and meta-analysis of randomised controlled trials of psychological interventions to improve gly-caemic control in patients with type 2 diabetes. Lancet 2004; 363 (9421): 1589-97.
128. Cuijpers P, Smit F. Subthreshold depression as a risk indicator for major depressive disorder: a systematic review of prospective studies. Acta Psychiatr Scand. 2004; 109 (5): 325-31.
129. Paile-Hyvarinen M, Wahlbeck K, Eriksson JG. Quality of life and metabolic status in mildly depressed women with type 2 diabetes treated with paroxetine: A single-blind randomised placebo controlled trial. BMC Fam Pract. 2003; 4, 7.
130. Christensen H, Griffiths KM, Jorm AF. Delivering intervention for depression by using the internet: randomised controlled trial. Br Med J. 2004; 328: 625.